Correlation Between Iteos Therapeutics and OmniAb
Can any of the company-specific risk be diversified away by investing in both Iteos Therapeutics and OmniAb at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iteos Therapeutics and OmniAb into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iteos Therapeutics and OmniAb Inc, you can compare the effects of market volatilities on Iteos Therapeutics and OmniAb and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iteos Therapeutics with a short position of OmniAb. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iteos Therapeutics and OmniAb.
Diversification Opportunities for Iteos Therapeutics and OmniAb
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Iteos and OmniAb is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Iteos Therapeutics and OmniAb Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OmniAb Inc and Iteos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iteos Therapeutics are associated (or correlated) with OmniAb. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OmniAb Inc has no effect on the direction of Iteos Therapeutics i.e., Iteos Therapeutics and OmniAb go up and down completely randomly.
Pair Corralation between Iteos Therapeutics and OmniAb
Given the investment horizon of 90 days Iteos Therapeutics is expected to generate 2.77 times less return on investment than OmniAb. But when comparing it to its historical volatility, Iteos Therapeutics is 1.53 times less risky than OmniAb. It trades about 0.0 of its potential returns per unit of risk. OmniAb Inc is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 394.00 in OmniAb Inc on August 30, 2024 and sell it today you would lose (4.00) from holding OmniAb Inc or give up 1.02% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Iteos Therapeutics vs. OmniAb Inc
Performance |
| Timeline |
| Iteos Therapeutics |
| OmniAb Inc |
Iteos Therapeutics and OmniAb Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Iteos Therapeutics and OmniAb
The main advantage of trading using opposite Iteos Therapeutics and OmniAb positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iteos Therapeutics position performs unexpectedly, OmniAb can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OmniAb will offset losses from the drop in OmniAb's long position.| Iteos Therapeutics vs. Annexon | Iteos Therapeutics vs. Monte Rosa Therapeutics | Iteos Therapeutics vs. Design Therapeutics | Iteos Therapeutics vs. Erasca Inc |
| OmniAb vs. Legend Biotech Corp | OmniAb vs. Verona Pharma PLC | OmniAb vs. Ideaya Biosciences | OmniAb vs. Iteos Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |